Search - tctmd.com

Displaying 261 - 280 of 563

Sort: Relevancy | Date

News Industry News

BIOTRONIK Announces New Study Evaluating Efficacy of Combined Pulsar-18 Stent and Passeo-18 Lux Balloon in Treating SFA Disease

July 17, 2014

News Daily News

HOST-ASSURE: Promus Element Noninferior to Resolute in All-Comers Population

July 10, 2014

News Daily News

HOST-ASSURE: Promus Element No es Inferior al Resolute en una Población de Pacientes No Seleccionados

July 10, 2014

News Daily News

HOST-ASSURE：在一般人群中，Promus Element不比Resolute差

July 10, 2014

News Daily News

Greater Early LV Mass Regression After TAVR Reduces Rehospitalization

June 27, 2014

News Daily News

EVAR Safer Than Surgery Even in Low-Risk Men

June 27, 2014

News Daily News

SYMPLICITY HTN-2: La Denervación Renal es Segura y Eficaz a los 3 Años

Yael L. Maxwell

June 11, 2014

News Daily News

Subestudio del Ensayo ROCKET AF: Rivaroxaban, Igual de Bueno que Warfarina en Pacientes Ancianos

June 11, 2014

News Daily News

SYMPLICITY HTN-2: Renal Denervation Safe, Effective at 3 Years

Yael L. Maxwell

June 11, 2014

News Daily News

ROCKET AF Substudy: Rivaroxaban as Good as Warfarin in Elderly Patients

June 11, 2014

News Daily News

Mortality Data for CAS Can Tease Out Poorly Performing Medicare Hospitals

Caitlin E. Cox

June 09, 2014

News Industry News

Medtronic Expands Availability of Market-Leading Aortic & Peripheral Solutions to U.S. Market

June 04, 2014

News Daily News

ILLUMENATE First-in-Human Study: Novel Drug-Coated Balloon Yields Strong 2-Year Outcomes in SFA Lesions

May 30, 2014

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

News Conference News EuroPCR 2014

Studies Document Initial Steps Toward Percutaneous Mitral Valve Replacement

Caitlin E. Cox

May 23, 2014

News Conference News EuroPCR 2014

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Yael L. Maxwell

May 22, 2014

News Conference News EuroPCR 2014

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

Caitlin E. Cox

May 20, 2014

News Daily News

Cardiac Stress Imaging at 5 Years Post-PCI Holds Prognostic Value

Caitlin E. Cox

May 14, 2014

News Daily News

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

May 14, 2014

News Industry News

Elixir Medical Receives CE Mark Approval for the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System

May 13, 2014

Advertisement

BIOTRONIK Announces New Study Evaluating Efficacy of Combined Pulsar-18 Stent and Passeo-18 Lux Balloon in Treating SFA Disease

HOST-ASSURE: Promus Element Noninferior to Resolute in All-Comers Population

HOST-ASSURE: Promus Element No es Inferior al Resolute en una Población de Pacientes No Seleccionados

HOST-ASSURE：在一般人群中，Promus Element不比Resolute差

Greater Early LV Mass Regression After TAVR Reduces Rehospitalization

EVAR Safer Than Surgery Even in Low-Risk Men

SYMPLICITY HTN-2: La Denervación Renal es Segura y Eficaz a los 3 Años

Subestudio del Ensayo ROCKET AF: Rivaroxaban, Igual de Bueno que Warfarina en Pacientes Ancianos

SYMPLICITY HTN-2: Renal Denervation Safe, Effective at 3 Years

ROCKET AF Substudy: Rivaroxaban as Good as Warfarin in Elderly Patients

Mortality Data for CAS Can Tease Out Poorly Performing Medicare Hospitals

Medtronic Expands Availability of Market-Leading Aortic & Peripheral Solutions to U.S. Market

ILLUMENATE First-in-Human Study: Novel Drug-Coated Balloon Yields Strong 2-Year Outcomes in SFA Lesions

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Studies Document Initial Steps Toward Percutaneous Mitral Valve Replacement

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

Cardiac Stress Imaging at 5 Years Post-PCI Holds Prognostic Value

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

Elixir Medical Receives CE Mark Approval for the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content